Globular glial tauopathy Type I presenting with behavioral variant frontotemporal dementia.


Journal

Neuropathology : official journal of the Japanese Society of Neuropathology
ISSN: 1440-1789
Titre abrégé: Neuropathology
Pays: Australia
ID NLM: 9606526

Informations de publication

Date de publication:
Oct 2020
Historique:
received: 06 11 2019
revised: 24 12 2019
accepted: 15 01 2020
entrez: 19 1 2021
pubmed: 20 1 2021
medline: 19 8 2021
Statut: ppublish

Résumé

Globular glial tauopathy (GGT) is a recently proposed tauopathy characterized by the globular accumulation of four-repeat (4R) tau in the oligodendroglia (globular oligodendroglial inclusion (GOI)) and astrocytes (globular astrocytic inclusion (GAI)), in addition to deposition in neurons. Although it is proposed that GGT should be classified into three different neuropathological subtypes, previous reports have indicated that subclassification might be difficult in some cases. We report an autopy case of a 79-year-old man with behavioral variant frontotemporal dementia (bvFTD). He developed behavioral changes at 67 years of age and had auditory hallucinations and persecutory delusions at admission to a psychiatric hospital at 69 years of age. Neuropathologically, marked atrophy of the frontotemporal lobes and severe degeneration of the white matter and frontopontine tract were observed. The present case corresponded to GGT Type I, as numerous GOIs were observed, predominantly in the frontotemporal region. However, concurrent degeneration of the motor cortex and corticospinal tract suggest characteristics of Type II. Although the relationship between psychotic symptoms and GGT remains unclear, the present case demonstrates heterogeneity of GGT subtypes.

Identifiants

pubmed: 33463808
doi: 10.1111/neup.12668
doi:

Substances chimiques

tau Proteins 0

Types de publication

Case Reports

Langues

eng

Sous-ensembles de citation

IM

Pagination

515-525

Subventions

Organisme : Grants-in Aid from the Research Committee of CNS Degenerative Diseases, Research on Policy Planning and Evaluation for Rare and Intractable Diseases, Health, Labour and Welfare Sciences Research Grants, the Ministry of Health, Labour and Welfare, Japan
Organisme : Ministry of Health, Labour and Welfare, Japan
Organisme : Japan Agency for Medical Research and Development
ID : JP18dm0107105
Organisme : Japan Agency for Medical Research and Development
ID : JP19dm0107108h
Organisme : Japan Agency for Medical Research and Development
ID : JP19ek0109391
Organisme : Japan Agency for Medical Research and Development
ID : JP19ek0109392
Organisme : Japan Agency for Medical Research and Development
ID : JP19kk0205022
Organisme : Japan Society for the Promotion of Science
ID : JP17K10294
Organisme : Japan Society for the Promotion of Science
ID : JP19K17059

Informations de copyright

© 2020 Japanese Society of Neuropathology.

Références

Ahmed Z, Doherty KM, Silveira‐Moriyama L et al. Globular glial tauopathies (GGT) presenting with motor neuron disease or frontotemporal dementia: An emerging group of 4‐repeat tauopathies. Acta Neuropathol 2011; 122: 415–428.
Ahmed Z, Bigio EH, Budka H et al. Globular glial tauopathies (GGT): Consensus recommendations. Acta Neuropathol 2013; 126: 537–544.
Josephs KA, Katsuse O, Beccano‐Kelly DA et al. Atypical progressive supranuclear palsy with corticospinal tract degeneration. J Neuropathol Exp Neurol 2006; 65: 396–405.
Kovacs GG, Majtenyi K, Spina S et al. White matter tauopathy with globular glial inclusions: A distinct sporadic frontotemporal lobar degeneration. J Neuropathol Exp Neurol 2008; 67: 963–975.
Fu YJ, Nishihira Y, Kuroda S et al. Sporadic four‐repeat tauopathy with frontotemporal lobar degeneration, Parkinsonism, and motor neuron disease: A distinct clinicopathological and biochemical disease entity. Acta Neuropathol 2010; 120: 21–32.
Burrell JR, Forrest S, Bak TH, Hodges JR, Halliday GM, Kril JJ. Expanding the phenotypic associations of globular glial tau subtypes. Alzheimers Dement (Amst) 2016; 4: 6–13.
Tanaka H, Kawakatsu S, Toyoshima Y et al. Globular glial tauopathy Type II: Clinicopathological study of two autopsy cases. Neuropathology 2019; 39: 111–119.
Kon T, Mori F, Arai A et al. Atypical globular glial tauopathy with a combination of types I and II pathology. Neuropathology 2019; 39: 127–134.
Kim KW, Lee DY, Jhoo JH et al. Diagnostic accuracy of mini‐mental status examination and revised Hasegawa dementia scale for Alzheimer's disease. Dement Geriatr Cogn Disord 2005; 19: 324–330.
Takahashi N, Kawamura M. Oral tendency due to frontal lobe lesion. Neurology 2001; 57: 739–740.
Rascovsky K, Hodges JR, Knopman D et al. Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain 2011; 134: 2456–2477.
Takeuchi R, Toyoshima Y, Tada M et al. Globular glial mixed four repeat tau and TDP‐43 proteinopathy with motor neuron disease and frontotemporal dementia. Brain Pathol 2016; 26: 82–94.
Montine TJ, Phelps CH, Beach TG et al. National Institute on Aging‐Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease: A practical approach. Acta Neuropathol 2012; 123: 1–11.
Thal DR, Rüb U, Orantes M, Braak H. Phases of A beta‐deposition in the human brain and its relevance for the development of AD. Neurology 2002; 58: 1791–1800.
Braak H, Braak E. Neuropathological stageing of Alzheimer‐related changes. Acta Neuropathol 1991; 82: 239–259.
Braak H, Alafuzoff I, Arzberger T, Kretzschmar H, Del Tredici K. Staging of Alzheimer disease‐associated neurofibrillary pathology using paraffin sections and immunocytochemistry. Acta Neuropathol 2006; 112: 389–404.
Mirra SS, Heyman A, McKeel D et al. The consortium to establish a registry for Alzheimer's disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 1991; 41: 479–486.
Arai T, Ikeda K, Akiyama H et al. Identification of amino‐terminally cleaved tau fragments that distinguish progressive supranuclear palsy from corticobasal degeneration. Ann Neurol 2004; 55: 72–79.
Mendez MF, Shapira JS, Woods RJ, Licht EA, Saul RE. Psychotic symptoms in frontotemporal dementia: Prevalence and review. Dement Geriatr Cogn Disord 2008; 25: 206–211.
Snowden JS, Rollinson S, Thompson JC et al. Distinct clinical and pathological characteristics of frontotemporal dementia associated with C9ORF72 mutations. Brain 2012; 135: 693–708.
Giaccone G, Marcon G, Mangieri M et al. Atypical tauopathy with massive involvement of the white matter. Neuropathol Appl Neurobiol 2008; 34: 468–472.
Shinagawa S, Nakajima S, Plitman E et al. Psychosis in frontotemporal dementia. J Alzheimers Dis 2014; 42: 485–499.
Ferrer I, Hernandez I, Boada M et al. Primary progressive aphasia as the initial manifestation of corticobasal degeneration and unusual tauopathies. Acta Neuropathol 2003; 106: 419–435.
Hiraga A, Uzawa A, Kamitsukasa I. Diffusion weighted imaging in ataxic hemiparesis. J Neurol Neurosurg Psychiatry 2007; 78: 1260–1262.
Jang SH, Chang PH, Kim YK, Seo JP. Anatomical location of the frontopontine fibers in the internal capsule in the human brain: A diffusion tensor tractography study. Neuroreport 2014; 25: 117–121.
Hasegawa I, Takeda A, Hatsuta H et al. An autopsy case of globular glial tauopathy presenting with clinical features of motor neuron disease with dementia and iron deposition in the motor cortex. Neuropathology 2018; 38: 372–379.
Piao YS, Tan CF, Iwanaga K et al. Sporadic four‐repeat tauopathy with frontotemporal degeneration, Parkinsonism and motor neuron disease. Acta Neuropathol 2005; 110: 600–609.
Powers JM, Byrne NP, Ito M et al. A novel leukoencephalopathy associated with tau deposits primarily in white matter glia. Acta Neuropathol 2003; 106: 181–187.
Molina JA, Probst A, Villanueva C et al. Primary progressive aphasia with glial cytoplasmic inclusions. Eur Neurol 1998; 40: 71–77.
Clark CN, Lashley T, Mahoney CJ, Warren JD, Revesz T, Rohrer JD. Temporal variant frontotemporal dementia is associated with globular glial tauopathy. Cogn Behav Neurol 2015; 28: 92–97.
Graff‐Radford J, Josephs KA, Parisi JE, Dickson DW, Giannini C, Boeve BF. Globular glial tauopathy presenting as semantic variant primary progressive aphasia. JAMA Neurol 2016; 73: 123–125.

Auteurs

Mitsuaki Hirano (M)

Department of Psychiatry, Nagoya University Graduate School of Medicine, Nagoya, Japan.

Shuji Iritani (S)

Department of Psychiatry, Nagoya University Graduate School of Medicine, Nagoya, Japan.

Hiroshige Fujishiro (H)

Department of Psychiatry, Nagoya University Graduate School of Medicine, Nagoya, Japan.

Youta Torii (Y)

Department of Psychiatry, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Department of Psychiatry, Moriyama General Psychiatric Hospital, Nagoya, Japan.

Kunihiro Kawashima (K)

Department of Psychiatry, Moriyama General Psychiatric Hospital, Nagoya, Japan.

Hirotaka Sekiguchi (H)

Department of Psychiatry, Nagoya University Graduate School of Medicine, Nagoya, Japan.

Chikako Habuchi (C)

Department of Psychiatry, Nagoya University Graduate School of Medicine, Nagoya, Japan.

Kentaro Yamada (K)

Department of Neurology, Nagoya City East Medical Center, Nagoya, Japan.

Toshimasa Ikeda (T)

Department of Neurology, Nagoya City East Medical Center, Nagoya, Japan.
Department of Neuropathology, Institute for Medical Science of Aging, Nagakute, Japan.

Masato Hasegawa (M)

Department of Dementia and Higher Brain Function, Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan.

Takeshi Ikeuchi (T)

Department of Molecular Genetics, Brain Research Institute, Niigata University, Niigata, Japan.

Mari Yoshida (M)

Department of Neuropathology, Institute for Medical Science of Aging, Nagakute, Japan.

Norio Ozaki (N)

Department of Psychiatry, Nagoya University Graduate School of Medicine, Nagoya, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH